Boğaziçi University Center for Targeted Therapy Technologies

Boğaziçi CT3 (Center for Targeted Therapy Technologies of Boğaziçi University) is a prominent research center within Boğaziçi University (Istanbul, Türkiye), focusing on innovative and high-impact research in life sciences and technologies. The center leverages Boğaziçi University's strengths in natural and applied sciences to drive technological advancements, not only in the rapidly advancing fields of medical biotechnology, but also within a novel set of “smart” in vivo biomedical devices. It fosters active collaborations between academia, industry, and healthcare sector with its recently updated sharp focus on targeted therapy technologies. Established within one of nation’s leading universities, Boğaziçi University’s CT3 supports multidisciplinary research and is the national trailblazer when it comes to successful technology transfer, academic spin-off and commercialization activities from biomedical and biotechnological academic innovations.

CT3 is a spinoff of the Center for Life Sciences and Technologies (Boğaziçi LifeSci). Boğaziçi LifeSci has been established in 2010, which brought together more than 50 academicians from 13 different departments/institutes within Boğaziçi University. Fostering multidisciplinary research, it established over the years several key research infrastructures within the university:

·        in vivo Medical Device Development Unit (Cleanroom), Test-Analysis Unit and Animal Care and Production Unit have become operational at Boğaziçi LifeSci’s inception phase (2009-2015). The dedicated cleanroom supports in vivo medical device development, from early R&D to clinical-grade pilot production (ISO 13485 accredited), ready for clinical trials and use.

·        Animal Imaging Unit, Pilot Production Facilities and Microalgae Biorefinery have been added subsequently with assistance from several national and international funds (2016 -2023). Pilot Production Facilities are of CT3 are GMP-ready and being used by SME’s for prototyping and small-scale production of several novel medical biotechnology products.